Table 1.
Characteristic | Median (range) or number |
---|---|
Sex | |
Male, n | 275 |
Female, n | 237 |
Age, years; median (range) | 37 (18–89) |
Risperidone daily dose (mg); median (range) | 3 (0.5–12) |
Risperidone and 9-hydroxyrisperidone measurements | |
In total, n | 1565 |
Per subject; median (range) | 2 (1–41) |
Risperidone dosing frequency prior to sampling, n | |
One dose per day | 789 |
Two doses per day | 758 |
Three doses per day | 18 |
Time between dose and sampling, hours; median (range) | 13 (9–30) |
CYP2D6 allele, n | |
*1 | 401* |
*35 | 54 |
*2-rs5758550A | 27 |
*2-rs5758550G | 166* |
*9 | 20 |
*10 | 23 |
*41 | 66 |
*3, 4, 5, or 6 (deficient alleles) | 269 |
CYP3A4 allele, n | |
*1 | 939 |
*22 | 27 |
Not determined | 58 |
NFIB allele, n | |
T | 965 |
C | 53 |
Not determined | 6 |
*Two subjects contributed 3 alleles (i.e., *1/*1 xN, n = 1 and *2-rs5758550G/*2-rs5758550G xN, n = 1)